Bismuth containing quadruple and concomitant therapy for 2 weeks are effective for the first-line Helicobacter pylori eradication: A prospective randomized trial

被引：0
|
作者：
Woo, H. [1 ]
Chung, J. [1 ]
Kim, S. [1 ]
Kim, J. [1 ]
Kwon, K. [1 ]
Kim, K. [1 ]
Kim, Y. [1 ]
Park, D. [1 ]
机构：
[1] Gachon Univ, Gil Med Ctr, Incheon, South Korea
来源：
HELICOBACTER | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.39
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
    Gisbert, Javier P.
    Calvet, Xavier
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 : 23 - 34
  • [42] Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
    Veysari, Arash Kazemi
    Rahimi, Ali
    Maleki, Iradj
    Fakheri, Hafez Tirgar
    Taghvaei, Tarang
    Hosseini, Vahid
    Toosi, Seyed Mohammad Valizadeh
    Masoumi, Danial
    Bari, Zohreh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (04) : 676 - 680
  • [43] Non-Bismuth Quadruple Therapy, Sequential Therapy or High-Dose Esomeprazole and Amoxicillin Dual Therapy for First-Line Helicobacter pylori Eradication: A Prospective Randomized Study
    Meriem, Zeriouh
    Elmekkaoui, Amine
    Bouqfar, Mouna
    Zazour, Abdelkrim
    Khannoussi, Wafaa
    Kharrasse, Ghizlane
    Abda, Naima
    Ismaili, Zahi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [44] Two weeks sequential and concomitant therapy for Helicobacter pylori infection and factors associated with eradication: A prospective randomized trial
    Lim, Ji Hyun
    Lee, Dong Ho
    Choi, Chiun
    Lee, Seong Tae
    Kim, Nayoung
    Park, Young Soo
    Shin, Cheol Min
    Cho, Hyun Jin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 60 - 60
  • [45] Efficacy and safety of bismuth-containing quadruple treatment and concomitant treatment for first-line Helicobacter pylori eradication: A systematic review and meta-analysis
    Guo, Biao
    Cao, Nv-Wei
    Zhou, Hao-Yue
    Chu, Xiu-Jie
    Li, Bao-Zhu
    MICROBIAL PATHOGENESIS, 2021, 152
  • [46] Comparing the efficacy of concomitant therapy with sequential therapy as the first-line therapy of Helicobacter pylori eradication
    Choi, M.
    HELICOBACTER, 2016, 21 : 141 - 141
  • [47] Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
    Jung, Sung Min
    Cheung, Dae Young
    Kim, Jin Il
    Kim, Il
    Seong, Hyeonjin
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [48] Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial
    Tian, Xue-li
    Suo, Bao-jun
    Zhang, Hua
    Lu, Hao-ping
    Li, Cai-ling
    Zhang, Yu-xin
    Ren, Xin-lu
    Yao, Xing-yu
    Zhou, Li-ya
    Song, Zhi-qiang
    HELICOBACTER, 2023, 28 (01)
  • [49] TAILORED VERSUS BISMUTH QUADRUPLE VERSUS CONCOMITANT THERAPY FOR THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI IN CHINESE PATIENTS: A MULTICENTRE, OPEN-LABEL, RANDOMIZED CONTROL TRIAL
    Zhou, L.
    Song, Z.
    Zhang, J.
    Qian, J.
    Li, Y.
    Bai, P.
    Wang, Y.
    Xue, Y.
    HELICOBACTER, 2014, 19 : 80 - 80
  • [50] Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial
    Suo Baojun
    Tian Xueli
    Zhang Hua
    Lu Haoping
    Li Cailing
    Zhang Yuxin
    Ren Xinlu
    Yao Xingyu
    Zhou Liya
    Song Zhiqiang
    中华医学杂志(英文版), 2023, 136 (08)
12345